Exenatide and renal failure

Diabetic Medicine

Volumn 27, Issue 6, 2010, Pages 728-729

  Ferrer Garcia, J C ^a   Martinez Chanza, N ^a   Tolosa Torrens M ^a   Sanchez Juan C ^a  

^a General Hospital of Valencia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EXENDIN 4; METFORMIN; REPAGLINIDE; ANTIDIABETIC AGENT; PEPTIDE; VENOM;

ADULT; CASE REPORT; CHRONIC KIDNEY DISEASE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOTENSION; KIDNEY FAILURE; LETTER; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; TREATMENT WITHDRAWAL; VOMITING; BODY MASS; COHORT ANALYSIS; DELIVERY; DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY; PREGNANCY DIABETES MELLITUS; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; WAIST CIRCUMFERENCE; CHEMICALLY INDUCED DISORDER; MIDDLE AGED;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MIDDLE AGED; PEPTIDES; RENAL INSUFFICIENCY; RISK FACTORS; VENOMS;

EID: 85047681163     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03009.x     Document Type: Letter

References (5)

1. Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH et al. LEAD-6 Study Group Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallelgroup, multinational, open-label trial (LEAD-6). Lancet 2009; 374: 3947.
2. Zinman B, Hoogwerf BJ, Duran Garc?a S, Milton DR, Giaconia JM, Kim DD et al. The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med 2007; 146: 477485.
3. Linnebjerg H, Kothare PA, Park S, Mace K, Reddy S, Mitchell M, et al. Effect of renal impairment on the pharmacokinetics of exenatide. Br J Clin Pharmacol 2007; 64: 317627.
4. Food and Drug Administration. Safety Alerts for Human Medical Products. Available at www.fda.gov ? Safety ? MedWatch ? Safety Information ? SafetyAlertsforHumanMedicalProducts ? ucm188703. htm Last accessed 5 February 2010.
5. Weise WJ, Sivanandy MS, Block CA, Comi RJ. Exenatide-associated ischemic renal failure. Diabetes Care 2009; 32: 2223